Decatur Capital Management Inc. lowered its position in shares of UnitedHealth Group Inc (NYSE:UNH) by 2.2% during the 2nd quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor owned 45,870 shares of the healthcare conglomerate’s stock after selling 1,049 shares during the quarter. UnitedHealth Group accounts for about 2.1% of Decatur Capital Management Inc.’s investment portfolio, making the stock its 11th largest position. Decatur Capital Management Inc.’s holdings in UnitedHealth Group were worth $11,193,000 at the end of the most recent reporting period.
Several other hedge funds also recently added to or reduced their stakes in UNH. Canton Hathaway LLC purchased a new position in shares of UnitedHealth Group in the first quarter worth $36,000. Truvestments Capital LLC purchased a new stake in UnitedHealth Group during the first quarter valued at $42,000. Creative Financial Designs Inc. ADV raised its stake in UnitedHealth Group by 89.6% during the first quarter. Creative Financial Designs Inc. ADV now owns 201 shares of the healthcare conglomerate’s stock valued at $50,000 after purchasing an additional 95 shares in the last quarter. Financial Gravity Wealth Inc. purchased a new stake in UnitedHealth Group during the first quarter valued at $58,000. Finally, Horan Capital Advisors LLC. purchased a new stake in UnitedHealth Group during the first quarter valued at $68,000. 85.87% of the stock is currently owned by hedge funds and other institutional investors.
UNH stock traded up $0.80 during mid-day trading on Friday, reaching $250.05. 2,677,617 shares of the stock traded hands, compared to its average volume of 3,780,643. The company has a debt-to-equity ratio of 0.62, a current ratio of 0.67 and a quick ratio of 0.73. UnitedHealth Group Inc has a one year low of $208.07 and a one year high of $287.94. The firm has a market cap of $236.87 billion, a PE ratio of 17.78, a PEG ratio of 1.33 and a beta of 0.61. The company has a 50-day simple moving average of $251.52.
UnitedHealth Group (NYSE:UNH) last posted its quarterly earnings data on Thursday, July 18th. The healthcare conglomerate reported $3.60 earnings per share for the quarter, beating the Zacks’ consensus estimate of $3.46 by $0.14. UnitedHealth Group had a net margin of 5.51% and a return on equity of 25.20%. The business had revenue of $60.60 billion for the quarter, compared to analysts’ expectations of $60.59 billion. During the same quarter in the previous year, the business posted $3.14 earnings per share. The business’s revenue was up 8.0% compared to the same quarter last year. As a group, equities analysts anticipate that UnitedHealth Group Inc will post 14.82 earnings per share for the current year.
In other UnitedHealth Group news, Director Richard T. Burke sold 10,000 shares of the business’s stock in a transaction on Wednesday, May 29th. The shares were sold at an average price of $241.99, for a total transaction of $2,419,900.00. Following the transaction, the director now owns 187,663 shares in the company, valued at $45,412,569.37. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at this hyperlink. Also, Director William C. Ballard, Jr. sold 12,000 shares of the business’s stock in a transaction on Tuesday, July 23rd. The shares were sold at an average price of $255.31, for a total transaction of $3,063,720.00. Following the transaction, the director now owns 61,309 shares in the company, valued at approximately $15,652,800.79. The disclosure for this sale can be found here. Insiders have sold 37,000 shares of company stock worth $9,158,720 in the last quarter. Company insiders own 0.87% of the company’s stock.
A number of research firms recently issued reports on UNH. UBS Group began coverage on shares of UnitedHealth Group in a research note on Tuesday, April 23rd. They set a “neutral” rating and a $238.00 price target on the stock. Raymond James upped their price target on shares of UnitedHealth Group from $265.00 to $300.00 and gave the company a “buy” rating in a research note on Friday, July 19th. Bank of America reaffirmed a “buy” rating and set a $290.00 price target (down previously from $320.00) on shares of UnitedHealth Group in a research note on Wednesday, April 17th. Cleveland Research reaffirmed a “buy” rating on shares of UnitedHealth Group in a research note on Monday, July 15th. Finally, SunTrust Banks decreased their price target on shares of UnitedHealth Group to $300.00 and set a “buy” rating on the stock in a research note on Wednesday, April 17th. They noted that the move was a valuation call. One equities research analyst has rated the stock with a sell rating, one has issued a hold rating and eighteen have issued a buy rating to the company. UnitedHealth Group has a consensus rating of “Buy” and a consensus price target of $295.06.
About UnitedHealth Group
UnitedHealth Group Incorporated operates as a diversified health care company in the United States. It operates through four segments: UnitedHealthcare, OptumHealth, OptumInsight, and OptumRx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health and well-being services to individuals age 50 and older, addressing their needs for preventive and acute health care services, as well as services dealing with chronic disease and other specialized issues for older individuals; and Medicaid plans, Children's Health Insurance Program, and health care programs; and health and dental benefits.
Recommended Story: Quiet Period Expirations
Want to see what other hedge funds are holding UNH? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for UnitedHealth Group Inc (NYSE:UNH).
Receive News & Ratings for UnitedHealth Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for UnitedHealth Group and related companies with MarketBeat.com's FREE daily email newsletter.